21035-26-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(1H-benzimidazol-2-yl)-3-ethylurea is used as a medication for the treatment of gastrointestinal conditions such as peptic ulcers, irritable bowel syndrome, and gastritis. It serves as a muscarinic receptor antagonist, reducing the symptoms associated with these conditions by blocking the parasympathetic nervous system's effects on the digestive system.
Used in Gastroenterology:
In the field of gastroenterology, 1-(1H-benzimidazol-2-yl)-3-ethylurea is used as an anticholinergic agent to manage gastrointestinal motility disorders. Its ability to block acetylcholine receptors helps in controlling symptoms like abdominal pain and cramps, providing relief to patients suffering from gastrointestinal issues.
Used in Oral Medication Form:
1-(1H-benzimidazol-2-yl)-3-ethylurea is available in oral tablet form, making it a convenient and accessible treatment option for patients. It is typically prescribed to be taken multiple times a day, as directed by a healthcare professional, ensuring optimal therapeutic effects and patient compliance.
Check Digit Verification of cas no
The CAS Registry Mumber 21035-26-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,0,3 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 21035-26:
(7*2)+(6*1)+(5*0)+(4*3)+(3*5)+(2*2)+(1*6)=57
57 % 10 = 7
So 21035-26-7 is a valid CAS Registry Number.
21035-26-7Relevant academic research and scientific papers
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents
Basarab, Gregory S.,Manchester, John I.,Bist, Shanta,Boriack-Sjodin, P. Ann,Dangel, Brian,Illingworth, Ruth,Sherer, Brian A.,Sriram, Shubha,Uria-Nickelsen, Maria,Eakin, Ann E.
, p. 8712 - 8735 (2013/12/04)
The discovery and optimization of a new class of bacterial topoisomerase (DNA gyrase and topoisomerase IV) inhibitors binding in the ATP domain are described. A fragment molecule, 1-ethyl-3-(2-pyridyl)urea, provided sufficiently potent enzyme inhibition (
Facile preparation of fused ring azolylureas
Drumm, Joseph E.,Deininger, David D.,LeTiran, Arnaud,Wang, Tiansheng,Grillot, Anne-Laure,Liao, Yusheng,Ronkin, Steven M.,Stamos, Dean P.,Tang, Qing,Tian, Shi-Kai,Oliver-Shaffer, Patricia
, p. 5535 - 5538 (2008/02/13)
Two novel reagents for the preparation of fused ring azolylureas are presented.
